Arkema Shares Jump 2.47% Following UBS Target Upgrade
The specialty chemicals company's stock made significant gains this Thursday, March 12, trading at 55.90 euros during the session, marking a 2.47% increase from the previous day's close of 54.55 euros. This rise occurs as the CAC 40 falls by 0.38% during the session to 8,011.60 points, amid a generally cautious European context.
The rebound in Arkema's shares follows a recent move by Swiss bank UBS, which issued a buy recommendation on the stock on March 10, raising its price target from 61 to 62 euros. At the current price of 55.90 euros, this target suggests a potential appreciation of about 10.9%. However, the group is still down by -30.13% over the year, although it has recovered 5.08% in the last three months. On the financial calendar, the next key dates are the publication of the first quarter 2026 results, scheduled for May 6, followed by the annual general meeting set for May 21. These events could provide new insights into the operational trajectory of the specialty chemist.
Technical Breakthrough in Today's Session
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Technically, today's session marks a crossing of the 50-day moving average (MM50), positioned at 55.61 euros. This move above a closely watched threshold is a notable signal, especially since the price had been below this reference for several sessions. The 200-day moving average, at 56.69 euros, now becomes the next zone to cross to confirm a possible more sustained turnaround. The Relative Strength Index (RSI) stands at 36, still close to the oversold zone (below 30), reflecting the selling pressure accumulated in recent weeks. The most relevant technical support is established at 50.85 euros. The SBF 120, the reference index to which Arkema belongs, meanwhile loses 0.33% in the session, at 6,065.45 points, highlighting the relative outperformance of the stock this Thursday.
Tout en restant attentif aux impacts potentiels de la crise au Moyen-Orient sur la demande mondiale, le coût des intrants et les perturbations des chaînes d'approvisionnement
Risks mentioned
Impact potentiel de la crise au Moyen-Orient sur la demande mondiale.
Inflation des coûts des intrants résultant de la crise au Moyen-Orient.
Opportunities identified
Développement dans des marchés clés attractifs tels que les batteries et l'impression 3D.
Poursuite des efforts pour gérer strictement les coûts fixes.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
